Drug Shortage Report for RENVELA
Report ID | 71284 |
Drug Identification Number | 02354586 |
Brand name | RENVELA |
Common or Proper name | Renvela |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | Sevelamer Carbonate |
Strength(s) | 800MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 180 |
ATC code | V03AE |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2019-01-03 |
Estimated end date | 2019-01-11 |
Actual end date | 2019-01-09 |
Shortage status | Resolved |
Updated date | 2019-01-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2019-01-10 | French | Compare |
v3 | 2019-01-10 | English | Compare |
v2 | 2019-01-04 | French | Compare |
v1 | 2019-01-04 | English | Compare |
Showing 1 to 4 of 4